Harvest Portfolios Group Inc. Has $55.03 Million Stock Holdings in Stryker Corporation $SYK

Harvest Portfolios Group Inc. boosted its holdings in shares of Stryker Corporation (NYSE:SYK) by 2.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 148,868 shares of the medical technology company’s stock after purchasing an additional 3,883 shares during the quarter. Harvest Portfolios Group Inc.’s holdings in Stryker were worth $55,032,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. Kovack Advisors Inc. boosted its position in shares of Stryker by 3.6% in the second quarter. Kovack Advisors Inc. now owns 771 shares of the medical technology company’s stock valued at $305,000 after acquiring an additional 27 shares during the period. Armstrong Advisory Group Inc. raised its stake in Stryker by 12.3% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 247 shares of the medical technology company’s stock valued at $91,000 after purchasing an additional 27 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in Stryker by 1.4% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,904 shares of the medical technology company’s stock valued at $704,000 after purchasing an additional 27 shares during the period. Patriot Financial Group Insurance Agency LLC increased its holdings in shares of Stryker by 3.9% during the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 745 shares of the medical technology company’s stock worth $275,000 after purchasing an additional 28 shares during the period. Finally, Wolff Wiese Magana LLC raised its position in shares of Stryker by 2.3% during the third quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock valued at $470,000 after buying an additional 28 shares during the last quarter. 77.09% of the stock is owned by institutional investors.

Stryker Price Performance

Shares of SYK stock opened at $387.34 on Friday. The stock’s fifty day simple moving average is $363.17 and its 200 day simple moving average is $369.21. Stryker Corporation has a one year low of $329.16 and a one year high of $404.87. The firm has a market cap of $148.23 billion, a price-to-earnings ratio of 46.11, a P/E/G ratio of 2.26 and a beta of 0.87. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.89 and a quick ratio of 1.21.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The company had revenue of $7.17 billion during the quarter, compared to analysts’ expectations of $7.12 billion. During the same period last year, the business earned $4.01 earnings per share. The business’s revenue was up 11.4% on a year-over-year basis. On average, analysts expect that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a yield of 0.9%. Stryker’s dividend payout ratio is 41.90%.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of Stryker stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the transaction, the director owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 5.90% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

SYK has been the topic of several research reports. The Goldman Sachs Group set a $399.00 price target on Stryker in a research note on Friday, January 9th. BTIG Research lifted their price objective on Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Truist Financial cut their target price on Stryker from $400.00 to $392.00 and set a “hold” rating for the company in a research note on Thursday, December 18th. TD Cowen cut Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price for the company. in a research report on Monday, January 26th. Finally, Raymond James Financial raised shares of Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price target on the stock in a report on Tuesday, January 6th. Thirteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $426.47.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.